/Companies

Caelum Biosciences

New York, US · Founded 2015 · Delaware corporation

Find your way into Caelum Biosciences

Sign up to see every warm intro you have to Caelum Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Caelum Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MS
Michael SpectorExecutive
MG
Martin GoldmanNamed on SEC filing
KW
Kenneth W. CappellNamed on SEC filing
WN
William NatbonyNamed on SEC filing
JP
Jeffrey PaleyNamed on SEC filing
DH
David HorinNamed on SEC filing

Board

LA
Lindsay A. RosenwaldBoard director
MS
Michael S. WeissBoard director

Reported raises · per SEC filings

Form D private placements

$9.9M disclosed across 1 round · 2017

▶$9.9MraisedSep 2017 · 167 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin GoldmanDirector
  • Lindsay A. RosenwaldDirector
  • Kenneth W. CappellDirector
  • Michael S. WeissDirector
  • Michael SpectorExecutive Officer, Director
  • William NatbonyDirector
  • Jeffrey PaleyDirector
  • David HorinExecutive Officer
Offering amount
$10M
Amount sold
$9.9M
Sales commissions
$991.4K
Placement agents
National Securities Corporation
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Caelum Biosciences raised?
Caelum Biosciences has disclosed $9.9M raised across 1 round.
Where is Caelum Biosciences headquartered?
Caelum Biosciences is headquartered in New York, US.